These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 30617807)
1. In Vivo Calpain Knockdown Using Delivery of siRNA. Liu X; Hu G Methods Mol Biol; 2019; 1915():219-232. PubMed ID: 30617807 [TBL] [Abstract][Full Text] [Related]
2. Long-term silencing of intersectin-1s in mouse lungs by repeated delivery of a specific siRNA via cationic liposomes. Evaluation of knockdown effects by electron microscopy. Bardita C; Predescu D; Predescu S J Vis Exp; 2013 Jun; (76):. PubMed ID: 23851900 [TBL] [Abstract][Full Text] [Related]
3. Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury. Liu D; Yan Z; Minshall RD; Schwartz DE; Chen Y; Hu G Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L370-9. PubMed ID: 22140070 [TBL] [Abstract][Full Text] [Related]
4. Intracellular localization of lipoplexed siRNA in vascular endothelial cells of different mouse tissues. Aleku M; Fisch G; Möpert K; Keil O; Arnold W; Kaufmann J; Santel A Microvasc Res; 2008 May; 76(1):31-41. PubMed ID: 18455200 [TBL] [Abstract][Full Text] [Related]
5. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
6. Suppression of NHE1 by small interfering RNA inhibits HIF-1α-induced angiogenesis in vitro via modulation of calpain activity. Mo XG; Chen QW; Li XS; Zheng MM; Ke DZ; Deng W; Li GQ; Jiang J; Wu ZQ; Wang L; Wang P; Yang Y; Cao GY Microvasc Res; 2011 Mar; 81(2):160-8. PubMed ID: 21185840 [TBL] [Abstract][Full Text] [Related]
7. Use of recombinant calpain-2 siRNA adenovirus to assess calpain-2 modulation of lung endothelial cell migration and proliferation. Qiu K; Su Y; Block ER Mol Cell Biochem; 2006 Nov; 292(1-2):69-78. PubMed ID: 16733798 [TBL] [Abstract][Full Text] [Related]
8. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. Leus NG; Morselt HW; Zwiers PJ; Kowalski PS; Ruiters MH; Molema G; Kamps JA Int J Pharm; 2014 Jul; 469(1):121-31. PubMed ID: 24746643 [TBL] [Abstract][Full Text] [Related]
9. Calpastatin is regulated by protein never in mitosis gene A interacting-1 (PIN1) in endothelial cells. Liu T; Schneider RA; Hoyt DG Biochem Biophys Res Commun; 2011 Oct; 414(3):581-6. PubMed ID: 21982763 [TBL] [Abstract][Full Text] [Related]
10. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
11. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Santel A; Aleku M; Keil O; Endruschat J; Esche V; Fisch G; Dames S; Löffler K; Fechtner M; Arnold W; Giese K; Klippel A; Kaufmann J Gene Ther; 2006 Aug; 13(16):1222-34. PubMed ID: 16625243 [TBL] [Abstract][Full Text] [Related]
12. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Wang S; Peng Q; Zhang J; Liu L Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204 [TBL] [Abstract][Full Text] [Related]
13. PD150606 protects against ischemia/reperfusion injury by preventing μ-calpain-induced mitochondrial apoptosis. Luo T; Yue R; Hu H; Zhou Z; Yiu KH; Zhang S; Xu L; Li K; Yu Z Arch Biochem Biophys; 2015 Nov; 586():1-9. PubMed ID: 26091952 [TBL] [Abstract][Full Text] [Related]
14. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo. Kowalski PS; Zwiers PJ; Morselt HW; Kuldo JM; Leus NG; Ruiters MH; Molema G; Kamps JA J Control Release; 2014 Feb; 176():64-75. PubMed ID: 24389338 [TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system. Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854 [TBL] [Abstract][Full Text] [Related]
16. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA. Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006 [TBL] [Abstract][Full Text] [Related]
17. Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells. Kowalski PS; Lintermans LL; Morselt HW; Leus NG; Ruiters MH; Molema G; Kamps JA Mol Pharm; 2013 Aug; 10(8):3033-44. PubMed ID: 23819446 [TBL] [Abstract][Full Text] [Related]
18. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery. Podesta JE; Kostarelos K Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563 [TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles. Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283 [TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of optimized liposomes for delivery of small interfering RNA. Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]